Core Viewpoint - Hongxing Technology is facing significant challenges in its IPO journey, with declining financial performance, supply chain vulnerabilities, and questionable financial practices, raising concerns about its market competitiveness and operational integrity [1][3][20]. Financial Performance - Revenue has declined sharply, with 2022 revenue at 651 million yuan, down 22% year-on-year, and 2023 revenue further decreasing to 542 million yuan, a 16.87% drop, nearly reverting to five years ago levels [2][5]. - Net profit for 2023 plummeted to 133 million yuan, a 31.60% decrease compared to the previous year [2]. Supply Chain Vulnerabilities - Over 60% of the company's base materials are sourced from Japan's Sanwa Group, with a significant reliance on Kyocera Group, which poses a competitive threat as it is the fourth-largest quartz crystal manufacturer globally [6][7]. - The company has a high dependency on imported chips, reaching 76%, indicating a fragile supply chain that could be disrupted by international market changes [7]. Financial Anomalies - The latest prospectus reveals concerning financial data, including a 10.79% increase in prepaid accounts, outpacing the 10.55% growth in operating costs, suggesting potential fund misappropriation [8]. - The construction in progress surged by 655.17% to 50 million yuan, raising suspicions of earnings manipulation [9]. Related Party Transactions - Complex relationships exist between Hongxing Technology and its controlling shareholder, Lin Honghe, with significant sales through related parties raising doubts about transaction authenticity [12][14]. - The gross margin from sales to related parties is significantly lower than that from third-party sales, indicating potential pricing issues [14]. Research and Development Shortcomings - R&D expenditure has consistently fallen below industry averages, with a 2022 R&D expense ratio of 5.17%, lower than the comparable company average of 7.26% [15][16]. - The company has shown an unusual pattern in patent acquisition, with no new patents for a decade before suddenly obtaining eight in a short period [16]. Dividend and Fundraising Concerns - The company has distributed 481 million yuan in cash dividends from 2020 to 2022, representing 85.62% of net profits, exceeding regulatory limits [18][19]. - Despite a healthy cash flow, the rationale for a 200 million yuan fundraising plan to supplement working capital is questioned, especially after a significant drop in dividends in 2023 [20].
鸿星科技IPO：4.8亿分红与2亿补流背后的业绩迷途
Sou Hu Cai Jing·2025-07-25 05:15